PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-10-06

Date Title Company
06-Oct-2025 GordonMD Global Investments® Backs Star Therapeutics in $125 Million Series D Financing Businesswire
06-Oct-2025 Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZeneca Businesswire
06-Oct-2025 Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) Businesswire
06-Oct-2025 Revvity to Hold Earnings Call on Monday, October 27, 2025 Businesswire
06-Oct-2025 I2Pure Celebrates Zimmer Biomet's Historic Approval of Iodine-Treated Implant System & Confirms AAHKS Attendance Businesswire
06-Oct-2025 Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy Businesswire
06-Oct-2025 Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event Businesswire
06-Oct-2025 API Innovation Center Report Spotlights Cross-Sector Dialogue on Drug Shortages Businesswire
06-Oct-2025 TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III Businesswire
06-Oct-2025 Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies Businesswire
06-Oct-2025 Health sector faces growing HR challenge from GDPR breaches, warns workplace wellbeing expert Reward Gateway | Edenred
06-Oct-2025 Stoke Therapeutics Appoints Ian F. Smith as Chief Executive Officer Businesswire
06-Oct-2025 Protein Engineering for Pharmaceutical Biotechnology Training Course | Enhance Your Knowledge in Protein Engineering to Understand How to Advance Therapeutic Developments (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com Businesswire
06-Oct-2025 Aqemia to Participate in Jefferies European Disruptive Tech Conference Businesswire
06-Oct-2025 CareDx Announces New IVD Products and IVDR Certification for AlloSeq® Tx and QTYPE® at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting Businesswire
06-Oct-2025 KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer Businesswire
06-Oct-2025 DEA Marijuana Cruelty Disguised as Process: Will President Trump Stop Delay on Cannabis Medicine For Huntington's and MS Patients ACCESS Newswire
06-Oct-2025 Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases Businesswire
06-Oct-2025 Within3 Names Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting Businesswire
06-Oct-2025 Owlstone Medical Wins up to $49.1 Million Award from ARPA-H to Develop At-home Multi-Cancer-Early Detection Tests Businesswire